Tehseen Salimi

980 total citations
31 papers, 276 citations indexed

About

Tehseen Salimi is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Tehseen Salimi has authored 31 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Tehseen Salimi's work include Acute Myeloid Leukemia Research (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Neutropenia and Cancer Infections (5 papers). Tehseen Salimi is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Neutropenia and Cancer Infections (5 papers). Tehseen Salimi collaborates with scholars based in United States, United Kingdom and France. Tehseen Salimi's co-authors include Robert S. Epstein, Cynthia J. Girman, Amer M. Zeidan, Courtney Schlusser, Upal Kunal Basu Roy, Matti Aapro, Jeffrey Crawford, Ali Çimen, Mark Sostek and Lynn Andrews and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tehseen Salimi

25 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tehseen Salimi United States 10 87 77 55 51 39 31 276
Milena Gobbo Spain 12 35 0.4× 39 0.5× 19 0.3× 73 1.4× 21 0.5× 25 345
Bruce C. M. Wang United States 11 34 0.4× 73 0.9× 16 0.3× 26 0.5× 37 0.9× 15 289
A Loganayagam United Kingdom 8 169 1.9× 43 0.6× 61 1.1× 7 0.1× 48 1.2× 15 288
Samit Patel United States 11 67 0.8× 47 0.6× 47 0.9× 63 1.2× 30 0.8× 25 294
Melanie Kripp Germany 11 159 1.8× 140 1.8× 22 0.4× 12 0.2× 100 2.6× 24 319
B. Joseph Elmunzer United States 8 193 2.2× 202 2.6× 29 0.5× 21 0.4× 123 3.2× 15 442
Michelle Brown United Kingdom 8 77 0.9× 28 0.4× 57 1.0× 24 0.5× 45 1.2× 23 344
Kris Bauchmüller United Kingdom 7 48 0.6× 40 0.5× 59 1.1× 79 1.5× 50 1.3× 18 239
Priyanka Mishra India 9 34 0.4× 46 0.6× 23 0.4× 128 2.5× 22 0.6× 40 311
Valgerður Sigurðardóttir Sweden 9 69 0.8× 73 0.9× 38 0.7× 19 0.4× 17 0.4× 25 367

Countries citing papers authored by Tehseen Salimi

Since Specialization
Citations

This map shows the geographic impact of Tehseen Salimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tehseen Salimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tehseen Salimi more than expected).

Fields of papers citing papers by Tehseen Salimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tehseen Salimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tehseen Salimi. The network helps show where Tehseen Salimi may publish in the future.

Co-authorship network of co-authors of Tehseen Salimi

This figure shows the co-authorship network connecting the top 25 collaborators of Tehseen Salimi. A scholar is included among the top collaborators of Tehseen Salimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tehseen Salimi. Tehseen Salimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Ruizhi, et al.. (2026). Trifluridine–Tipiracil with and without Bevacizumab in Colorectal Cancer. NEJM Evidence. 5(3). EVIDoa2500120–EVIDoa2500120.
2.
3.
4.
Epstein, Robert S., et al.. (2024). Time toxicity for patients receiving oral versus parenteral hypomethylating agents for myelodysplastic syndromes/neoplasms (MDS).. Journal of Clinical Oncology. 42(16_suppl). 6568–6568. 1 indexed citations
5.
Zeidan, Amer M., Namita Joshi, Hrishikesh Kale, et al.. (2022). Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes. Clinical Lymphoma Myeloma & Leukemia. 22(9). 670–679. 4 indexed citations
6.
7.
8.
Epstein, Robert S., Upal Kunal Basu Roy, Matti Aapro, et al.. (2021). Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life. Patient Preference and Adherence. Volume 15. 453–465. 22 indexed citations
9.
Epstein, Robert S., Matti Aapro, Upal Kunal Basu Roy, et al.. (2020). Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors. Advances in Therapy. 37(8). 3606–3618. 65 indexed citations
10.
Epstein, Robert S., et al.. (2020). Real-world burden of chemotherapy-induced myelosuppression: Results of a U.S. online survey of patients with cancer.. Journal of Clinical Oncology. 38(15_suppl). e19299–e19299.
11.
Epstein, Robert S., et al.. (2020). Real-world burden of myelosuppression in patients with small cell lung cancer (SCLC): Retrospective, longitudinal data analysis.. Journal of Clinical Oncology. 38(15_suppl). e19300–e19300. 4 indexed citations
12.
Gan, Tong J., et al.. (2018). Practice Patterns and Treatment Challenges in Acute Postoperative Pain Management: A Survey of Practicing Physicians. Pain and Therapy. 7(2). 205–216. 26 indexed citations
13.
Epstein, Robert S., J. Russell Teagarden, Ali Çimen, Mark Sostek, & Tehseen Salimi. (2017). When People with Opioid-Induced Constipation Speak: A Patient Survey. Advances in Therapy. 34(3). 725–731. 14 indexed citations
14.
Salimi, Tehseen, et al.. (2017). The Effect of Spiritual Self-Care Group Therapy on Life Expectancy in Patients with Coronary Artery Disease: An Educational Trial. 15(10). 917–928. 12 indexed citations
15.
Iqbal, Sheikh Usman, Tehseen Salimi, John Dunlop, & L. Clark Paramore. (2016). The Early Engagement Model in Product Development: Linking “Proof of Concept” to “Proof of Medical Value”. Therapeutic Innovation & Regulatory Science. 50(5). 592–601. 4 indexed citations
16.
Epstein, Robert S., et al.. (2014). Patient Preferences for Change in Symptoms Associated with Opioid-Induced Constipation. Advances in Therapy. 31(12). 1263–1271. 13 indexed citations
17.
Salimi, Tehseen, et al.. (2012). Investigating the Effects of Defroxamine Injection on Physical Growth in Children with Thalassemia Major. SHILAP Revista de lepidopterología.
18.
Salimi, Tehseen, et al.. (2012). A framework for pharmaceutical value-based innovations. Journal of Comparative Effectiveness Research. 1(1s). 3–7. 8 indexed citations
19.
Epstein, Robert S., et al.. (2012). Integrating scientific and real-world evidence within and beyond the drug development process. Journal of Comparative Effectiveness Research. 1(1s). 9–13. 11 indexed citations
20.
Maini, Baltej S., et al.. (1993). A modified, angioscopically assisted technique for in situ saphenous vein bypass: Impact on patency, complications, and length of stay. Journal of Vascular Surgery. 17(6). 1041–1049. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milena Gobbo Breakdown of academic impact, for papers by Bruce C. M. Wang Breakdown of academic impact, for papers by A Loganayagam Breakdown of academic impact, for papers by Samit Patel Breakdown of academic impact, for papers by Melanie Kripp Breakdown of academic impact, for papers by B. Joseph Elmunzer Breakdown of academic impact, for papers by Michelle Brown Breakdown of academic impact, for papers by Kris Bauchmüller Breakdown of academic impact, for papers by Priyanka Mishra Breakdown of academic impact, for papers by Valgerður Sigurðardóttir
Rankless by CCL
2026